Evidence map›Paper›PMID 40861306›Full record

ArticleSchizophrenia bulletin open2025

Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program.

Jean Addington, Amy Shalev, Lu Liu, Cari Jahraus, Monica Chu, Emily Farina, Paolo Fusar Poli, Patricia J Marcy, Angela R Nunez, Monica E Calkins and 71 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

81 authors.

Jean AddingtonDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Amy ShalevDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Lu LiuDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Cari JahrausDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Monica ChuDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Emily FarinaDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States.
Paolo Fusar PoliDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, SE58AF, United Kingdom.
Patricia J MarcyNorthwell, Glen Oaks, NY 11004, United States.
Angela R NunezDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States.
Monica E CalkinsDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19063, United States.ORCID https://orcid.org/0000-0002-0546-0263
Luis AlamedaDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, SE58AF, United Kingdom.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Instituto de Salud Carlos III, School of Medicine, Universidad Complutense, 28009 Madrid, Spain.
Owen BordersDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Sylvain BouixDepartment of Software Engineering and Information Technology, École de Technologie Supérieure, Montréal, QC, H3C 1K3, Canada.
Nicholas J K BreitbordeDepartment of Psychiatry and Behavioral Health, Early Psychosis Intervention Center (EPICENTER), College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Matthew R BroomeInstitute for Mental Health, University of Birmingham, Birmingham, B152TT, United Kingdom.
Kristin S CadenheadUniversity of California, San Diego, La Jolla, CA 92104, United States.ORCID https://orcid.org/0000-0002-5952-4605
Ricardo E CarrionNorthwell, Glen Oaks, NY 11004, United States.
Rolando I Castillo-PassiDepartment of Psychiatry, University of Chile, 8330111 Santiago, Chile.
Eric Yu Hai ChenDepartment of Psychiatry, School of Clinical Medicine, LKF Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
Jimmy ChoiOlin Neuropsychiatry Research Center, Hartford HealthCare Behavioral Health Network, Hartford, CT 06106, United States.
Michael J ColemanDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Philippe ConusGeneral Psychiatry Service, Treatment and Early Intervention in Psychosis Program (TIPP-Lausanne), Lausanne University Hospital and University of Lausanne, 1003 Lausanne, Switzerland.
Cheryl M CorcoranDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Covadonga M Diaz-CanejaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Instituto de Salud Carlos III, School of Medicine, Universidad Complutense, 28009 Madrid, Spain.ORCID https://orcid.org/0000-0001-8538-3175
Lauren M EllmanDepartment of Psychology & Neuroscience, Temple University, Philadelphia, PA 19122-6085, United States.
Pablo A GasparDepartment of Psychiatry, University of Chile, 8330111 Santiago, Chile.
Carla GerberPrevention Science Institute, University of Oregon, Eugene, OR 97401, United States.
Louise Birkedal GlenthøjVIRTU Research Group, Mental Health Copenhagen, University of Copenhagen, 2900 Copenhagen, Denmark.
Leslie E HortonDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States.
Christy Lai Ming HuiDepartment of Psychiatry, School of Clinical Medicine, LKF Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
Joseph KambeitzDepartment of Psychiatry, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.ORCID https://orcid.org/0000-0002-8988-3959
Lana Kambeitz-IlankovicDepartment of Psychiatry, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Tina KapurDepartment of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.
Sinead KellyDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Melissa J KerrOrygen, Parkville, Victoria, 3052, Australia.
Matcheri S KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, United States.
Minah KimDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul 03082, South Korea.
Sung-Wan KimDepartment of Psychiatry, Chonnam National University Medical School, Gwangju 61469, South Korea.ORCID https://orcid.org/0000-0002-6739-2163
Nikolaos KoutsoulerisDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, SE58AF, United Kingdom.
Jun Soo KwonDepartment of Psychiatry, Seoul National University College of Medicine, Seoul 03080, South Korea.ORCID https://orcid.org/0000-0002-1060-1462
Kerstin LangbeinDepartment of Psychiatry and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.
Kathryn E LewandowskiPsychotic Disorders Division, McLean Hospital, Belmont, MA 02478, United States.
Daniel MamahDepartment of Psychiatry, Washington University Medical School, St. Louis, MO 63110, United States.
Daniel H MathalonDepartment of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94121, United States.
Vijay A MittalDepartment of Psychology, Northwestern University, Evanston, IL 60201, United States.ORCID https://orcid.org/0000-0001-9017-5119
Catalina MourguesDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States.
Merete NordentoftVIRTU Research Group, Mental Health Copenhagen, University of Copenhagen, 2900 Copenhagen, Denmark.
Ofer PasternakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Godfrey D PearlsonDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States.
Nora PenzelDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Jesus PerezCAMEO, Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, Cambridgeshire, CB4 1PX, United Kingdom.
Diana O PerkinsDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, United States.
Albert R PowersDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States.ORCID https://orcid.org/0000-0003-3057-5043
Jack RogersInstitute for Mental Health, University of Birmingham, Birmingham, B152TT, United Kingdom.
Fred W SabbPrevention Science Institute, University of Oregon, Eugene, OR 97401, United States.
Jason SchiffmanDepartment of Psychological Science, University of California, Irvine, Irvine, CA 92697-7085, United States.
Johanna Seitz-HollandDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Jai L ShahDouglas Research Centre, Montreal, QC, H4H 1R3  Canada.ORCID https://orcid.org/0000-0002-7549-6990
Steven M SilversteinDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY 14642, United States.ORCID https://orcid.org/0000-0002-0699-0960
Stefan SmesnyDepartment of Psychiatry and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.
William S StoneDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0003-2932-7288
Gregory P StraussDepartment of Psychology, University of Georgia, Athens, GA 30602, United States.
Judy L ThompsonDepartments of Psychiatry and Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, United States.
Rachel UpthegroveInstitute for Mental Health, University of Birmingham, Birmingham, B152TT, United Kingdom.
Swapna VermaInstitute of Mental Health, Singapore 539747, Singapore.
Jijun WangShanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China.
Daniel H WolfDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19063, United States.
Alison R YungInstitute of Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Victoria, 3220, Australia.
Tianhong ZhangDepartment of Psychiatry, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China.ORCID https://orcid.org/0000-0002-5379-7119
Lauren AddamoOrygen, Parkville, Victoria, 3052, Australia.
Kate BuccilliOrygen, Parkville, Victoria, 3052, Australia.
Sophie ToddOrygen, Parkville, Victoria, 3052, Australia.
Dominic DwyerOrygen, Parkville, Victoria, 3052, Australia.ORCID https://orcid.org/0000-0003-3949-5867
Carrie E BeardenDepartments of Psychiatry and Biobehavioral Sciences and Psychology, Semel Institute for Neuroscience and Human Behavior; University of California, Los Angeles, Los Angeles, CA 90095,  United States.ORCID https://orcid.org/0000-0002-8516-923X
John M KaneDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY 11549, United States.ORCID https://orcid.org/0000-0002-2628-9442
Patrick D McGorryOrygen, Parkville, Victoria, 3052, Australia.
Rene S KahnDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Martha E ShentonDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115, United States.
Scott W WoodsDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States.
Accelerating Medicines Partnership® Schizophrenia Nelson Barnaby

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This paper presents the recruitment sources of clinical high-risk (CHR) and community controls (CC) from the Accelerating Medicines Partnership Schizophrenia (AMP SCZ) program, which aims to study various clinical variables and biomarkers in 2040 CHR and 652 CC participants. Methods: A total of 1640 CHR and 514 CC had recruitment source data. The Positive Symptoms and Diagnostic Criteria for the Comprehensive Assessment of At-Risk Mental States Harmonized with the SIPS was utilized to assess CHR criteria and severity of attenuated psychotic symptoms (APSs), and the Global Functioning: Social Scale was used for social functioning. Participants were recruited through various methods, including referrals from healthcare providers, schools, and community agencies, and self-referrals via outreach efforts and advertising. Results: Participants were recruited from 13 different sources, with self-referral being the most common for both CHR and CC. Other notable sources included child and youth services and psychiatric hospitals and departments. Regional differences in recruitment patterns were observed across continents. Differences in age, APS, and social functioning for CHR participants were examined in the top 5 recruitment sources. Overall, self-referred individuals were typically older, with less severe APS and higher levels of functioning, whereas those from adult community mental health services had poorer functioning and more severe APS. The remaining recruitment groups fell between these 2 extremes. Conclusion: This paper highlights the diverse recruitment sources for the AMP SCZ program. Self-referral was a significant source, particularly in North America, reflecting changing help-seeking behaviors influenced by the internet and social media. The findings underscore the importance of understanding recruitment sources to optimize future CHR research.

Indexed as

AMP SCZascertainmentclinical high riskcommunity controlspsychosisrecruitment

Identifiers

PMID40861306
PMCPMC12377801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.